Clinical trials recruiting for Thoracic Neoplasms
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Adebrelimab | 1 |
| Carboplatin | 1 |
| Carboplatin/Cisplatin | 1 |
| Cemiplimab | 1 |
| ESB Thoracic | 1 |
| Etoposide | 1 |
| MCT Diet | 1 |
| Paclitaxel | 1 |
| Tarlatamab | 1 |
| Teniposide administration | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| District of Columbia | 1 |
Top cities
Self-screener
Recruiting trials
- A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC
- Early Intervention Strategies for Lung Cancer
- Erector Spinae Block for Thoracic Surgery
- PALACE: Cemiplimab Trial According to ctDNA Levels
- Post-line Treatment With Teniposide for c-Myc-driven Extensive-stage Small Cell Lung Cancer
- Post-operative Medium Chain Triglyceride Diet May Reduce Hospital Stay Following Lung Resection
- Study of Tarlatamab as Maintenance Treatment After Chemo-radiotherapy for Limited Stage SCLC Patients
- The Effects of a Family-Centered Tai Chi Exercise on Lung Function and Mental Health of Patients After Thoracoscopic Surgery
Related conditions
Trials recruiting for Thoracic Neoplasms often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Thoracic Neoplasms trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.